Innovative Medicines Initiatives - Call 14
Innovative Medicine Initiative 2 has now published call 14. Deadline: June 14, 2018.
The Innovative Medicines Initiative 2 (IMI2) is a partnership between the European Union and the European pharmaceutical industry.
The following topics are included in the call 14. It is the same topics as IMI prepublished as drafts. The funding listed here is per project and divided among academic partners.
- Targeted immune intervention for treatment of non-response and remission
Funding: Between 4 032 000 and 16 128 000 EUR for different sub topics.
- Non-invasive clinical molecular imaging of immune cells
Funding: 15 000 000 EUR
- Development of a platform for federated and privacy-preserving machine learning in support of drug discovery
Funding: 8 000 000 EUR
- Centre of excellence – remote decentralised clinical trials
Funding: 19 037 000 EUR
First deadline: June 14th, 2018
Second deadline: December 11th, 2018
Please note that only one proposal will be invited to stage two
Link to call